Physician profile
John E Kroger
NPI 1538131024
$1,052.18
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $786 · 2020: $132 · 2021: $134.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $165.53 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $154.81 | 2019-2020 | |
| Pfizer INC. | $149.60 | 2019-2020 | |
| Glaxosmithkline, LLC. | $139.01 | 2019-2021 | |
| Novo Nordisk INC | $75.69 | 2019-2021 | |
| Amgen INC. | $61.57 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $58.93 | 2019-2021 | |
| Lilly USA, LLC | $57.54 | 2019 | |
| Novartis Pharmaceuticals Corporation | $33.30 | 2019 | |
| Amarin Pharma, INC. | $31.08 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.79 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $23.63 | 2021 | |
| Sanofi Pasteur INC. | $23.56 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.30 | 2019 | |
| Sanofi-Aventis U.S. LLC | $19.08 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $14.76 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kroger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.